ClearPoint Neuro, Inc.
CLPT- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001285550
No open-market purchases or sales by ClearPoint Neuro, Inc. insiders were filed in the last 90 days; 129 institutions reported holding it in 13F filings for Q2 2026, worth $247.9M in total; no superinvestor holds it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Oct 29, 2026, 1:13 AM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Net loss for FY2025: $25.5M (69.1% of revenue).
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 12, 2026 | Feb 26, 2025 | Jan 8, 2024 | Jan 11, 2023 | Feb 14, 2022 |
| Revenue | $37.0M | $31.4M | $24.0M | $20.6M | $16.3M |
| Cost of revenue | $14.3M | $12.3M | $10.3M | $7.02M | $5.01M |
| Gross profit | $22.7M | $19.1M | $13.6M | $13.5M | $11.3M |
| Research and development | $13.9M | $12.4M | $11.7M | $10.9M | $8.98M |
| Selling, general and administrative | $16.5M | $12.0M | $11.8M | $9.61M | $8.76M |
| Operating income | -$24.2M | -$19.7M | -$22.4M | -$16.3M | -$13.4M |
| Interest expense | – | – | – | $81.0K | $973.0K |
| Income tax | $55.0K | $12.0K | $8.00K | $0 | $0 |
| Net income | -$25.5M | -$18.9M | -$22.1M | -$16.4M | -$14.4M |
| EPS, basic | $-0.90 | $-0.70 | $-0.90 | $-0.68 | – |
| EPS, diluted | $-0.90 | $-0.70 | $-0.90 | $-0.68 | – |
| Weighted shares, basic | 28.3M | 27.0M | 24.6M | 24.2M | – |
| Weighted shares, diluted | 28.3M | 27.0M | 24.6M | 24.2M | – |
| Margins and growth | |||||
| Gross margin | 61.4% | 60.9% | 56.8% | 65.8% | 69.3% |
| Operating margin | -65.4% | -62.9% | -93.7% | -79.5% | -82.1% |
| Net margin | -69.1% | -60.3% | -92.2% | -80.0% | -88.4% |
| Revenue growth, year over year | +17.8% | +31.0% | +16.6% | +26.1% | +27.0% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 12, 2026 | Feb 26, 2025 | Jan 8, 2024 | Jan 11, 2023 | Feb 14, 2022 |
| Cash and equivalents | $45.9M | $20.1M | $23.1M | $27.6M | $54.1M |
| Short-term investments | – | – | $0 | $9.87M | – |
| Accounts receivable | $6.55M | $4.71M | $3.21M | $2.67M | $2.34M |
| Inventory | $8.36M | $6.86M | $7.91M | $9.30M | $4.94M |
| Total current assets | $63.6M | $33.4M | $36.2M | $51.2M | $61.9M |
| Property, plant and equipment | $2.62M | $2.00M | $1.39M | $806.0K | $539.0K |
| Goodwill | $7.47M | – | – | – | – |
| Intangible assets | $13.9M | – | – | – | – |
| Total assets | $97.7M | $39.2M | $42.7M | $55.5M | $65.6M |
| Accounts payable | $1.26M | $1.34M | $393.0K | $272.0K | $427.0K |
| Total current liabilities | $10.8M | $10.4M | $7.43M | $6.79M | $4.75M |
| Long-term debt | $49.1M | – | $9.95M | $9.89M | $9.84M |
| Total liabilities | $69.7M | $13.8M | $21.5M | $18.6M | $16.8M |
| Shareholders' equity | $28.0M | $25.4M | $21.2M | $36.9M | $48.8M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 12, 2026 | Feb 26, 2025 | Jan 8, 2024 | Jan 11, 2023 | Feb 14, 2022 |
| Operating cash flow | -$23.9M | -$8.95M | -$13.7M | -$16.2M | -$12.7M |
| Capital expenditures | $522.0K | $275.0K | $717.0K | $253.0K | $168.0K |
| Free cash flow | -$24.4M | -$9.22M | -$14.4M | -$16.4M | -$12.9M |
| Depreciation and amortization | $814.0K | $980.0K | $626.0K | $244.0K | $159.0K |
| Stock-based compensation | $8.18M | $6.91M | $6.08M | $4.13M | $2.08M |
| Investing cash flow | $615.0K | -$275.0K | $8.95M | -$10.7M | -$168.0K |
| Financing cash flow | $50.2M | $6.19M | $296.0K | $409.0K | $46.9M |
| Net change in cash | $26.9M | -$3.04M | -$4.47M | -$26.5M | $34.0M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 22.1% | 22.0% | 25.4% | 20.1% | 12.7% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Oct 21, 2026 | 32.1M | +12.8% | SEC |
| Jul 27, 2026 | 30.5M | +7.3% | SEC |
| May 7, 2026 | 30.0M | +7.1% | SEC |
| Mar 6, 2026 | 29.7M | +7.4% | SEC |
| Oct 27, 2025 | 28.4M | +3.0% | SEC |
| Aug 6, 2025 | 28.4M | +3.0% | SEC |
| May 7, 2025 | 28.0M | +2.1% | SEC |
| Feb 18, 2025 | 27.6M | +2.4% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.